Pulse Biosciences (PLSE) Other Non-Current Assets (2015 - 2026)
Pulse Biosciences (PLSE) posted Other Non-Current Assets of $403000.0 for Q2 2026, down 41.68% on a QoQ basis from $691000.0 in Q4 2025, and down 40.47% year-over-year from $677000.0 in Q2 2025.
Powered by 
Analysis
Pulse Biosciences (PLSE) Other Non-Current Assets (2015 - 2026) Analysis & Trends
Pulse Biosciences has reported Other Non-Current Assets for 12 years, with the latest figure at $403000.0 in Q2 2026.
- On a quarterly basis, Other Non-Current Assets fell 40.47% year-over-year to $403000.0 in Q2 2026; TTM through Jun 2026 was $403000.0, a 40.47% decrease from a year earlier, with the FY2025 full-year figure at $691000.0, up 2.07% from the prior year.
- Other Non-Current Assets was $403000.0 for Q2 2026 at Pulse Biosciences, down from $691000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $714000.0 in Q2 2024, with the low at $365000.0 in Q1 2022.
- Average Other Non-Current Assets over 5 years is $498588.2, with a median of $365000.0 recorded in 2022.
- The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets surged 95.62% in 2024, then slumped 40.47% in 2026.
- Over 5 years, Other Non-Current Assets stood at $365000.0 in 2022, then changed by 0.0% to $365000.0 in 2023, then soared by 85.48% to $677000.0 in 2024, then gained by 2.07% to $691000.0 in 2025, then sank by 41.68% to $403000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $403000.0 (Q2 2026), $691000.0 (Q4 2025), and $705000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Pulse Biosciences | 3.76 Bn | 3.76 Bn | 161,000.00 | 403,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 403,000.00 |
| Dec 31, 2025 | 691,000.00 |
| Sep 30, 2025 | 705,000.00 |
| Jun 30, 2025 | 677,000.00 |
| Mar 31, 2025 | 678,000.00 |
| Dec 31, 2024 | 677,000.00 |
| Sep 30, 2024 | 646,000.00 |
| Jun 30, 2024 | 714,000.00 |
| Mar 31, 2024 | 365,000.00 |
| Dec 31, 2023 | 365,000.00 |
| Sep 30, 2023 | 365,000.00 |
| Jun 30, 2023 | 365,000.00 |
| Mar 31, 2023 | 365,000.00 |
| Dec 31, 2022 | 365,000.00 |
| Sep 30, 2022 | 365,000.00 |
| Jun 30, 2022 | 365,000.00 |
| Mar 31, 2022 | 365,000.00 |
| Dec 31, 2021 | 365,000.00 |
| Sep 30, 2021 | 365,000.00 |
| Jun 30, 2021 | 365,000.00 |